BA
EDIT icon

BlackRock Advisors’s Editas Medicine EDIT Stock Holding History

BlackRock Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$99K Sell
6,072
-3,745
-38% -$56.8K ﹤0.01% 3042
2016
Q3 		$132K Buy
9,817
+990
+11% +$20.3K ﹤0.01% 2896
2016
Q2 		$215K Buy
8,827
+5,622
+175% +$190K ﹤0.01% 2563
2016
Q1 		$111K Buy
+3,205
New +$84.2K ﹤0.01% 2869

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock Advisors's EDIT Position: Q4 2016 in Review

BlackRock Advisors reduced its Editas Medicine (EDIT) stake by 38% in Q4 2016, selling an estimated $56.8K and leaving 6,072 shares worth $99K. The position accounts for ﹤0.01% of the portfolio, ranked #3042.

BlackRock Advisors first reported a position in EDIT in Q1 2016 and has held it in 4 quarters since. The position peaked at $215K in Q2 2016. 84 funds tracked by Wall St. Rank hold EDIT as of Q4 2016.

  • BlackRock Advisors held 6,072 shares of Editas Medicine worth $99K as of Q4 2016.
  • BlackRock Advisors sold 3,745 Editas Medicine shares in Q4 2016, an estimated $56.8K.
  • Editas Medicine made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3042 holding.
  • BlackRock Advisors first reported a position in Editas Medicine in Q1 2016 and has held it in 4 quarters since.
  • BlackRock Advisors's Editas Medicine position peaked at $215K in Q2 2016.
  • 84 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.